Save on Belatacept with Coupons, Discounts & Savings Programs

Belatacept is available as 250 mg per vial.

Belatacept is an immunosuppressant that is used for the prevention of kidney transplant rejection in adults.

Belatacept s a type of immunosuppressant called a selective T-cell costimulation blocker. It attaches to two spots on the surface of immune cells in your body. These immune cells normally activate (wake up) T-cells. By binding to these spots, it can stop T-cells from multiplying and causing rejection of your transplanted organ.

Belatacept is only available as an intravenous (IV) infusion through your vein that’s administered by a healthcare provider. The dose depends on your body weight and how much time has passed since your transplant. In general, you’ll follow a dosing schedule your transplant provider sets for you, and then eventually, you’ll only receive one dose per month.

Belatacept is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if you are EBV seronegative or with unknown EBV serostatus.

Common side effects of Belatacept:

• Anemia
• Changes in stool habits
• Urinary tract infection
• Swelling in your arms and legs
• Changes in blood pressure
• Fever
• Cough
• Vomiting
• Headache

Serious side effects are rare with Belatacept. Contact your healthcare provider immediately if you experience any of the following.

• Post-transplant lymphoproliferative disorder (PTLD): changes in mood or usual behavior, confusion, weakness, problems thinking, memory loss, changes in walking or talking, changes in vision
• Infection: fever, chills, muscle aches, change in appetite, weight loss, vomiting, skin rash

The following medications may interact with Belatacept:

• Monitor for a need to adjust concomitant mycophenolate mofetil (MMF) dosage whenna patient’s therapy is switched between cyclosporine and Belatacept
• Coadministration (at the same or nearly the same time) of anti-thymocyte globulin(or any other cell-depleting induction treatment) and Belatacept in kidney transplant recipients, especially those with other predisposing risk factors for venous thrombosis of the renal allograft, may pose a risk for venous thrombosis of the renal
• allograft

Various FDA-approved generic manufacturers

It is not known if Belatacept will harm your unborn baby. If you become pregnant while taking Belatacept: Tell your doctor right away.  You and your doctor should decide if you will keep receiving Belatacept while you are pregnant. Talk with your doctor about enrolling in the National Transplant Pregnancy Registry (NTPR). This Registry collects information about pregnancies in women who have received Belatacept or if their partner has received Belatacept, and had a transplant. You can also enroll by calling 1-877-955-6877.

• Nulojix